Skip to main content
Top
Published in: Medical Oncology 11/2015

01-11-2015 | Original Paper

Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology

Authors: Martin J. Magers, Tianyu Zhan, Aaron M. Udager, John T. Wei, Scott A. Tomlins, Angela J. Wu, Lakshmi P. Kunju, Madelyn Lew, Felix Y. Feng, Daniel A. Hamstra, Javed Siddiqui, Arul M. Chinnaiyan, Jeffrey S. Montgomery, Alon Z. Weizer, Todd M. Morgan, Brent K. Hollenbeck, David C. Miller, Ganesh S. Palapattu, Hui Jiang, Rohit Mehra

Published in: Medical Oncology | Issue 11/2015

Login to get access

Abstract

Anterior-predominant prostate cancer (APC) is an incompletely understood entity which can be difficult to sample via transrectal biopsy. Seemingly favorable biopsy results may belie the potential aggressiveness of these tumors. Here, we attempt to characterize APC by retrospectively examining the clinicopathologic features of APC at radical prostatectomy and comparing our findings with prior biopsy information. We found that 17.4 % of patients in our study had APC. APC demonstrated a significantly lower (P value < 0.05) Gleason score (GS) and pathologic stage than non-APC tumors, including the absence of seminal vesicle invasion by APC. A subset (5.6 %) of APC consisted of high-grade tumors (GS ≥ 8), and these tumors were more often detected on transperineal saturation biopsy than non-transperineal saturation (i.e., transrectal ultrasound guided) biopsy strategies. Four patients (7 %) without transperineal saturation biopsy exhibited a significantly worse GS at RP than biopsy, compared to five patients (36 %) with transperineal saturation biopsy. Our findings corroborate the difficulty in detecting APC and suggest that APC is not a uniform disease with a wholly indolent phenotype. Dedicated long-term outcome data are needed in these patients. Additionally, alternative pathologic staging parameters may be necessary.
Literature
2.
go back to reference Fine SW, Al-Ahmadie HA, Gopalan A, et al. Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis. Adv Anat Pathol. 2007;14:401–7.CrossRefPubMed Fine SW, Al-Ahmadie HA, Gopalan A, et al. Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis. Adv Anat Pathol. 2007;14:401–7.CrossRefPubMed
3.
go back to reference Fine SW, Reuter VE. Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer. Histopathology. 2012;60:142–52.CrossRefPubMed Fine SW, Reuter VE. Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer. Histopathology. 2012;60:142–52.CrossRefPubMed
4.
go back to reference Al-Ahmadie HA, Tickoo SK, Olgac S, et al. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol. 2008;32:229–35.CrossRefPubMed Al-Ahmadie HA, Tickoo SK, Olgac S, et al. Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy. Am J Surg Pathol. 2008;32:229–35.CrossRefPubMed
5.
go back to reference Mygatt J, Sesterhenn I, Rosner I, et al. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer Prostatic Dis. 2014;17:75–80.CrossRefPubMed Mygatt J, Sesterhenn I, Rosner I, et al. Anterior tumors of the prostate: clinicopathological features and outcomes. Prostate Cancer Prostatic Dis. 2014;17:75–80.CrossRefPubMed
6.
go back to reference Vargas SO, Jiroutek M, D’Amico AV, et al. Distribution of carcinoma in radical prostatectomy specimens in the era of serum prostate-specific antigen testing. Implications for delivery of localized therapy. Am J Clin Pathol. 1999;112:373–6.PubMed Vargas SO, Jiroutek M, D’Amico AV, et al. Distribution of carcinoma in radical prostatectomy specimens in the era of serum prostate-specific antigen testing. Implications for delivery of localized therapy. Am J Clin Pathol. 1999;112:373–6.PubMed
8.
go back to reference Mai KT, Moazin M, Morash C, et al. Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high psa with positive anterior margins in radical prostatectomy specimens. Urol Int. 2001;66:191–6.CrossRefPubMed Mai KT, Moazin M, Morash C, et al. Transitional zone and anterior peripheral zone of the prostate. A correlation of small-volume cancer in the biopsy cores and high psa with positive anterior margins in radical prostatectomy specimens. Urol Int. 2001;66:191–6.CrossRefPubMed
9.
go back to reference Sakamoto Y, Fukaya K, Haraoka M, et al. Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy. Prostate Int. 2014;2:114–20.PubMedCentralCrossRefPubMed Sakamoto Y, Fukaya K, Haraoka M, et al. Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy. Prostate Int. 2014;2:114–20.PubMedCentralCrossRefPubMed
10.
go back to reference Bouye S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate. 2009;69:105–13.CrossRefPubMed Bouye S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate. 2009;69:105–13.CrossRefPubMed
11.
go back to reference Bott SR, Young MP, Kellett MJ, et al. Anterior prostate cancer: Is it more difficult to diagnose? BJU Int. 2002;89:886–9.CrossRefPubMed Bott SR, Young MP, Kellett MJ, et al. Anterior prostate cancer: Is it more difficult to diagnose? BJU Int. 2002;89:886–9.CrossRefPubMed
12.
go back to reference Good DW, Stewart GD, Zakikhani P, et al. Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy. World J Urol. 2014;32:393–8.CrossRefPubMed Good DW, Stewart GD, Zakikhani P, et al. Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy. World J Urol. 2014;32:393–8.CrossRefPubMed
13.
go back to reference Bittner N, Merrick GS, Butler WM, et al. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol. 2013;190:509–14.CrossRefPubMed Bittner N, Merrick GS, Butler WM, et al. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol. 2013;190:509–14.CrossRefPubMed
14.
go back to reference Faisal FA, Sundi D, Pierorazio PM, et al. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature. BJU Int. 2014;114:E120–9.PubMedCentralCrossRefPubMed Faisal FA, Sundi D, Pierorazio PM, et al. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature. BJU Int. 2014;114:E120–9.PubMedCentralCrossRefPubMed
15.
go back to reference Terris MK, Freiha FS, McNeal JE, et al. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol. 1991;146:78–83.PubMed Terris MK, Freiha FS, McNeal JE, et al. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol. 1991;146:78–83.PubMed
16.
go back to reference Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging–initial results. Radiology. 2003;229:241–7.CrossRefPubMed Zakian KL, Eberhardt S, Hricak H, et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging–initial results. Radiology. 2003;229:241–7.CrossRefPubMed
17.
go back to reference Mehra R, Han B, Tomlins SA, et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res. 2007;67:7991–5.CrossRefPubMed Mehra R, Han B, Tomlins SA, et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res. 2007;67:7991–5.CrossRefPubMed
18.
go back to reference Epstein JI, Partin AW, Sauvageot J, et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 1996;20:286–92.CrossRefPubMed Epstein JI, Partin AW, Sauvageot J, et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 1996;20:286–92.CrossRefPubMed
19.
go back to reference Steuber T, Erbersdobler A, Graefen M, et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer. 2006;106:775–82.CrossRefPubMed Steuber T, Erbersdobler A, Graefen M, et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer. 2006;106:775–82.CrossRefPubMed
20.
go back to reference van der Kwast TH, Collette L, Van Poppel H, et al. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Arch. 2006;449:428–34.CrossRefPubMed van der Kwast TH, Collette L, Van Poppel H, et al. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Virchows Arch. 2006;449:428–34.CrossRefPubMed
21.
go back to reference Yossepowitch O, Briganti A, Eastham JA, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65:303–13.CrossRefPubMed Yossepowitch O, Briganti A, Eastham JA, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65:303–13.CrossRefPubMed
22.
go back to reference Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128:492–7.PubMed Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128:492–7.PubMed
23.
go back to reference Tiguert R, Gheiler EL, Tefilli MV, et al. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens. Prostate. 1998;37:230–5.CrossRefPubMed Tiguert R, Gheiler EL, Tefilli MV, et al. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens. Prostate. 1998;37:230–5.CrossRefPubMed
24.
go back to reference Sundi D, Kryvenko ON, Carter HB, et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol. 2014;191:60–7.PubMedCentralCrossRefPubMed Sundi D, Kryvenko ON, Carter HB, et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. J Urol. 2014;191:60–7.PubMedCentralCrossRefPubMed
25.
go back to reference Liu IJ, Macy M, Lai YH, et al. Critical evaluation of the current indications for transition zone biopsies. Urology. 2001;57:1117–20.CrossRefPubMed Liu IJ, Macy M, Lai YH, et al. Critical evaluation of the current indications for transition zone biopsies. Urology. 2001;57:1117–20.CrossRefPubMed
26.
go back to reference Bazinet M, Karakiewicz PI, Aprikian AG, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol. 1996;155:605–6.CrossRefPubMed Bazinet M, Karakiewicz PI, Aprikian AG, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol. 1996;155:605–6.CrossRefPubMed
27.
go back to reference Terris MK, Pham TQ, Issa MM, et al. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol. 1997;157:204–6.CrossRefPubMed Terris MK, Pham TQ, Issa MM, et al. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol. 1997;157:204–6.CrossRefPubMed
28.
go back to reference Morote J, Lopez M, Encabo G, et al. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur Urol. 1999;35:294–7.CrossRefPubMed Morote J, Lopez M, Encabo G, et al. Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur Urol. 1999;35:294–7.CrossRefPubMed
29.
go back to reference Maeda H, Ishitoya S, Aoki Y, et al. Value of systematic transition zone biopsy in the detection of prostate cancer. Int J Urol. 1997;4:567–71.CrossRefPubMed Maeda H, Ishitoya S, Aoki Y, et al. Value of systematic transition zone biopsy in the detection of prostate cancer. Int J Urol. 1997;4:567–71.CrossRefPubMed
30.
go back to reference Ishizuka O, Mimura Y, Oguchi T, et al. Importance of transition zone prostate biopsies in patients with gray-zone PSA levels undergoing the ultrasound-guided systematic ten-biopsy regimen for the first time. Urol Int. 2005;74:23–6.CrossRefPubMed Ishizuka O, Mimura Y, Oguchi T, et al. Importance of transition zone prostate biopsies in patients with gray-zone PSA levels undergoing the ultrasound-guided systematic ten-biopsy regimen for the first time. Urol Int. 2005;74:23–6.CrossRefPubMed
31.
go back to reference Fink KG, Hutarew G, Esterbauer B, et al. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology. 2003;61:748–53.CrossRefPubMed Fink KG, Hutarew G, Esterbauer B, et al. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology. 2003;61:748–53.CrossRefPubMed
32.
go back to reference Moussa AS, Meshref A, Schoenfield L, et al. Importance of additional “extreme” anterior apical needle biopsies in the initial detection of prostate cancer. Urology. 2010;75:1034–9.CrossRefPubMed Moussa AS, Meshref A, Schoenfield L, et al. Importance of additional “extreme” anterior apical needle biopsies in the initial detection of prostate cancer. Urology. 2010;75:1034–9.CrossRefPubMed
33.
go back to reference Elshafei A, Kartha G, Li Y, et al. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis. Prostate. 2014;74:1183–8.CrossRefPubMed Elshafei A, Kartha G, Li Y, et al. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis. Prostate. 2014;74:1183–8.CrossRefPubMed
34.
go back to reference Cole E, Margel D, Greenspan M, et al. Is there a role for anterior zone sampling as part of saturation trans-rectal ultrasound guided prostate biopsy? BMC Urol. 2014;14:34.PubMedCentralCrossRefPubMed Cole E, Margel D, Greenspan M, et al. Is there a role for anterior zone sampling as part of saturation trans-rectal ultrasound guided prostate biopsy? BMC Urol. 2014;14:34.PubMedCentralCrossRefPubMed
35.
go back to reference Eichler K, Hempel S, Wilby J, et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175:1605–12.CrossRefPubMed Eichler K, Hempel S, Wilby J, et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol. 2006;175:1605–12.CrossRefPubMed
36.
go back to reference Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int. 2007;99:1340–4.CrossRefPubMed Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int. 2007;99:1340–4.CrossRefPubMed
37.
go back to reference Falzarano SM, Zhou M, Hernandez AV, et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology. 2010;76:682–7.CrossRefPubMed Falzarano SM, Zhou M, Hernandez AV, et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology. 2010;76:682–7.CrossRefPubMed
38.
go back to reference Mabjeesh NJ, Lidawi G, Chen J, et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int. 2012;110:993–7.CrossRefPubMed Mabjeesh NJ, Lidawi G, Chen J, et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int. 2012;110:993–7.CrossRefPubMed
39.
go back to reference Ekwueme K, Simpson H, Zakhour H, et al. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int. 2013;111:E365–73.CrossRefPubMed Ekwueme K, Simpson H, Zakhour H, et al. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int. 2013;111:E365–73.CrossRefPubMed
40.
go back to reference Dimmen M, Vlatkovic L, Hole KH, et al. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int. 2012;110:E69–75.CrossRefPubMed Dimmen M, Vlatkovic L, Hole KH, et al. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int. 2012;110:E69–75.CrossRefPubMed
41.
go back to reference Pepe P, Garufi A, Priolo G, et al. Can 3-tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Clin Genitourin Cancer. 2014;13:e27–30.CrossRefPubMed Pepe P, Garufi A, Priolo G, et al. Can 3-tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Clin Genitourin Cancer. 2014;13:e27–30.CrossRefPubMed
42.
go back to reference Pepe P, Dibenedetto G, Pennisi M, et al. Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy. Urol Int. 2014;93:189–92.CrossRefPubMed Pepe P, Dibenedetto G, Pennisi M, et al. Detection rate of anterior prostate cancer in 226 patients submitted to initial and repeat transperineal biopsy. Urol Int. 2014;93:189–92.CrossRefPubMed
43.
go back to reference Vyas L, Acher P, Kinsella J, et al. Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int. 2014;114:32–7.CrossRefPubMed Vyas L, Acher P, Kinsella J, et al. Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int. 2014;114:32–7.CrossRefPubMed
44.
go back to reference Klatte T, Swietek N, Schatzl G, et al. Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies. Wien Klin Wochenschr. 2013;125:669–73.CrossRefPubMed Klatte T, Swietek N, Schatzl G, et al. Transperineal template-guided biopsy for diagnosis of prostate cancer in patients with at least two prior negative biopsies. Wien Klin Wochenschr. 2013;125:669–73.CrossRefPubMed
45.
go back to reference Gershman B, Zietman AL, Feldman AS, et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013;31:1093–7.CrossRefPubMed Gershman B, Zietman AL, Feldman AS, et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013;31:1093–7.CrossRefPubMed
46.
go back to reference Komai Y, Numao N, Yoshida S, et al. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013;190:867–73.CrossRefPubMed Komai Y, Numao N, Yoshida S, et al. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 2013;190:867–73.CrossRefPubMed
47.
go back to reference Ouzzane A, Puech P, Lemaitre L, et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology. 2011;78:1356–62.CrossRefPubMed Ouzzane A, Puech P, Lemaitre L, et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology. 2011;78:1356–62.CrossRefPubMed
48.
go back to reference Lemaitre L, Puech P, Poncelet E, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol. 2009;19:470–80.CrossRefPubMed Lemaitre L, Puech P, Poncelet E, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol. 2009;19:470–80.CrossRefPubMed
49.
go back to reference Volkin D, Turkbey B, Hoang AN, et al. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int. 2014;114:E43–9.CrossRefPubMed Volkin D, Turkbey B, Hoang AN, et al. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int. 2014;114:E43–9.CrossRefPubMed
50.
go back to reference Junker D, Schafer G, Kobel C, et al. Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis. AJR Am J Roentgenol. 2014;202:W263–9.CrossRefPubMed Junker D, Schafer G, Kobel C, et al. Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis. AJR Am J Roentgenol. 2014;202:W263–9.CrossRefPubMed
51.
go back to reference Pepe P, Garufi A, Priolo G, et al. Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res. 2013;33:1195–9.PubMed Pepe P, Garufi A, Priolo G, et al. Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy? Anticancer Res. 2013;33:1195–9.PubMed
52.
go back to reference Costa DN, Bloch BN, Yao DF, et al. Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. Magn Reson Imaging. 2013;31:947–52.PubMedCentralCrossRefPubMed Costa DN, Bloch BN, Yao DF, et al. Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. Magn Reson Imaging. 2013;31:947–52.PubMedCentralCrossRefPubMed
53.
go back to reference Baco E, Rud E, Ukimura O, et al. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer. Urol Oncol. 2014;32:1300–7.CrossRefPubMed Baco E, Rud E, Ukimura O, et al. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer. Urol Oncol. 2014;32:1300–7.CrossRefPubMed
54.
go back to reference Garcia-Reyes K, Passoni NM, Palmeri ML, et al. Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. 2014;40:134–42.CrossRef Garcia-Reyes K, Passoni NM, Palmeri ML, et al. Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. 2014;40:134–42.CrossRef
55.
go back to reference Ruprecht O, Weisser P, Bodelle B, et al. MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol. 2012;81:456–60.CrossRefPubMed Ruprecht O, Weisser P, Bodelle B, et al. MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol. 2012;81:456–60.CrossRefPubMed
56.
go back to reference Mullerad M, Hricak H, Wang L, et al. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology. 2004;232:140–6.CrossRefPubMed Mullerad M, Hricak H, Wang L, et al. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology. 2004;232:140–6.CrossRefPubMed
Metadata
Title
Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology
Authors
Martin J. Magers
Tianyu Zhan
Aaron M. Udager
John T. Wei
Scott A. Tomlins
Angela J. Wu
Lakshmi P. Kunju
Madelyn Lew
Felix Y. Feng
Daniel A. Hamstra
Javed Siddiqui
Arul M. Chinnaiyan
Jeffrey S. Montgomery
Alon Z. Weizer
Todd M. Morgan
Brent K. Hollenbeck
David C. Miller
Ganesh S. Palapattu
Hui Jiang
Rohit Mehra
Publication date
01-11-2015
Publisher
Springer US
Published in
Medical Oncology / Issue 11/2015
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-015-0693-9

Other articles of this Issue 11/2015

Medical Oncology 11/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.